Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2009 Apr-Jun;23(2):152-7.
doi: 10.1097/wad.0b013e318190a855.

The effect of APOE-epsilon4 on dementia is mediated by Alzheimer neuropathology

James A Mortimer  1 , David A Snowdon, William R Markesbery
Affiliations
Comparative Study

The effect of APOE-epsilon4 on dementia is mediated by Alzheimer neuropathology

James A Mortimer et al. Alzheimer Dis Assoc Disord. 2009 Apr-Jun.

Abstract

The degree to which the association of epsilon4 with dementia is mediated by AD lesions in comparison with vascular lesions is controversial. The present study was undertaken to determine the roles of Alzheimer disease (AD) and vascular pathology in mediating the effect of apolipoprotein E (APOE)-epsilon4 alleles on dementia. Clinicopathologic correlations were studied in 267 Catholic sisters participating in the Nun Study. The extent to which AD and vascular pathologies mediated the effect of APOEepsilon4 on dementia was investigated using multiple logistic regression. Adjusted for age at death and education, possession of 1 or more epsilon4 alleles was an important risk factor for dementia (odds ratio=2.98; 95% confidence interval, 1.62-5.48). This association was lost (odds ratio=1.38; 95% confidence interval, 0.68-2.80) when an index of the severity of AD-related neuropathology was added to the model, but changed little when measures of the severity of vascular pathology were added. The findings suggest that the effect of epsilon4 on dementia is mediated by the severity of AD pathology. Although infarcts and atherosclerosis contribute to the occurrence of dementia, this contribution seems unrelated to APOE genotype.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Xuereb JH, Brayne C, DuFouil C, et al. Neuropathological findings in the very old. Results from the first 101 brains of a population-based longitudinal study of dementing disorders. Ann NY Acad Sci. 2000;903:490–496. - PubMed
    1. White L, Small BJ, Petrovitch H, et al. Recent clinical-pathologic research on the causes of dementia in late life: Update from the Honolulu-Asia Aging study. J Geriatr Psychiatry Neurol. 2005;18:224–227. - PubMed
    1. Henderson AS, Easteal S, Jorm AF, et al. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample. Lancet. 1995;346:1387–1390. - PubMed
    1. Myers RH, Schaefer EJ, Wilson PW, et al. Apolipoprotein E ε4 association with dementia in a population-based study: The Framingham Study. Neurology. 1996;46:673–677. - PubMed
    1. Evans D, Beckett L, Field R, et al. Apolipoprotein E ε4 and incidence of Alzheimer's disease in a community population of older persons. JAMA. 1997;277:822–824. - PubMed

Publication types

MeSH terms

Substances